Clinical Trial Detail

NCT ID NCT04195945
Title CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

myeloid neoplasm

acute myeloid leukemia

Therapies

CPX-351

Cladribine + Cytarabine + Filgrastim + Mitoxantrone

Age Groups: adult senior

No variant requirements are available.